Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aussie Biotechs Look To Federal Budget For Research Support

This article was originally published in PharmAsia News

Executive Summary

Australian biotechs are looking for help in the federal budget for supporting life sciences in the wake of a 24 percent decline in research spending among startups in the first quarter. The decline is the biggest in the three years since the industry began analyzing research spending. Spending amounted to just under $30 million in the first quarter, compared with $39 million in the previous quarter. Australia's Commercial Ready grants program was cut in last year's budget, so the life sciences sector is awaiting the new budget and details for replacement programs. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071577

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel